Jing Li

机构：Georgia Institute of Technology, Guiyang Medical University, Xuzhou Medical College, Beijing Tian Tan Hospital, Lianyungang Oriental Hospital, Affiliated Hospital of Guizhou Medical University, The First People’s Hospital of Lianyungang · ORCID：0000-0001-8669-4901

发表论文 106 篇 · 总被引 1413 次 · h-index 21

代表论文

• Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma (2024 · Nature · 被引 30)
• Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence (2024 · Neuron · 被引 30)
• Olaparib in treatment‐refractory isocitrate dehydrogenase 1 ( IDH1 )– and IDH2 ‐mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer Institute 10129 trial (2025 · Cancer · 被引 13)
• Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma (2024 · Cell Communication and Signaling · 被引 12)
• Bioprinted Fibroblast Mediated Heterogeneous Tumor Microenvironment for Studying Tumor‐Stroma Interaction and Drug Screening (2025 · Advanced Healthcare Materials · 被引 8)
• The liquid-liquid phase separation in programmed cell death (2024 · Cellular Signalling · 被引 5)